The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center

The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center

Authors

  • Justyna Fijołek The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw https://orcid.org/0000-0002-9135-1580
  • Elzbieta Wiatr The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw
  • Dorota Piotrowska-Kownacka The First Department of Clinical Radiology, Independent Public Central Clinical Hospital of Medical University, Warsaw
  • Kazimierz Roszkowski-Sliz The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw

Keywords:

Eosinophilia, diagnostics, lung disorders

Abstract

Background: Eosinophilia is rare but one of the important reasons to refer patients to pneumonological centers. Determining etiology of eosinophilia has practical implications for therapeutic intervention and disease prognosis. The study aimed to determine the role of peripheral eosinophilia in the diagnosis of lung disorders.
Methods: To the retrospective study were included 46 patients diagnosed with peripheral eosinophilia with coexisting respiratory symptoms and/or radiologically detected lung lesions. All patients underwent standard diagnostic procedures, including a detailed clinical history review, physical examination, routine laboratory tests with basal cardiological examinations, and serological tests to detect parasites and allergies. Other procedures carried out depended on the symptoms of each patient. The relation between eosinophil counts in the blood and patients’ clinical manifestation was investigated to identify the degree of eosinophilia requiring immediate diagnostic procedures and treatment. Statistical analyses were performed using scientific computation libraries in the Python programming language, SciPy, v. 1.3.1. Briefly, the following tests were used: parametric Kruskal-Wallis H test, an independent t-test, ANOVA, the Shapiro-Wilk test, Fisher’s and Chi-squared tests, and the Holm-Bonferroni method.
Results: Severe eosinophilia (≥5,000 cells/μl) was associated with extrapulmonary involvement and constitutional symptoms. Skin, heart, and pleural diseases were more frequent in these patients than in patients with mild or moderate eosinophilia (p=0.010, p=0.040, and p=0.007, respectively), and only these patients showed signs of kidney disease (p=0.006). Vasculitis was significantly more frequent in the severe eosinophilia group (p=0.048) than in the other two groups. In patients with moderate eosinophilia (1,500-5,000 cells/μl), extrapulmonary symptoms were less common, although signs of cardiac involvement were confirmed in 44% of subjects. In this group, vasculitis was the most commonly observed disease (42% of cases). Mild eosinophilia (<1,500 cells/μl) was mainly associated with airway disease. In this group, vasculitis and interstitial lung diseases were identified, but most were not typically connected with eosinophilia.
Conclusions: Identification of peripheral eosinophilia may essentially determine diagnostic procedures in patients with lung disorders and may be a useful indicator of disease etiology.

References

Roufosse F. Weller PF. Practical approach to the patients with hypereosinophilia. J Allergy Clin Immunol 2010;126:39-44.

Wang SA. The diagnostic work-up of hypereosinophilia. Pathobiology 2019;86:39-52.

Wardlaw AJ. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 1994;70:536-52.

Bain BJ, Fletcher SH. Chronic eosinophilic leukemia and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 2007;27:377-88.

Cottin V. Eosinophilic lung diseases. Clin Chest Med 2016;37:535-56.

Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 2010;126:3-13.

Bernheim A, McLoud T. A review of clinical and imaging findings in eosinophilic lung diseases. AJR 2017;208:1002-10.

Hasegawa K, Stoll SJ, Ahn J, Bittner JC, Camargo CA Jr. Prevalence of eosinophilia in hospitalized patients with asthma exacerbation. Resp Med 2015;109:1230-32.

Jin HJ. Biological treatment for severe asthma. Yeungnam Univ J Med 2020;37:262-8.

Kim HB, Seo JW, Lee JH, Choi BS, Park SG. Evaluation of the prevalence and clinical impact of toxocariasis in patients with eosinophilia of unknown origin. Korean J Intern Med 2017;32:523-29.

Yoon SY, Baek S, Park SY, Shin B, Kwon HS, Cho YS, et al. Clinical course and treatment outcomes of toxocariasis-related eosinophilic disorder. Medicine 2018;97:37:e12361.

Okada R, Nakachi S, Inokuma S. The severity of peripheral blood eosinophilia indicates an eosinophilia-associated disease corresponding to its level. Allergol Int 2016;65:112-4.

Sade K, Mysels A, Levo Y, Kivity S. Eosinophilia: a study of 100 hospitalized patients. Eur J Intern Med 2007;18:196-201.

Bjerrum OW, Siersma V, Hasselbalch HC, Lind B. Association of the blood eosinophil count with end-organ symptoms. Ann Med Surg 2019;45:11-8.

Klion AD, Law MA, Riemenschneider W et al. Familial eosinophilia: a benign disorder? Blood 2004;103:4050-5.

Lombardi C, Passalacqua G. Eosinophilia and diseases: clinical revision of 1862 cases. Arch Intern Med 2003;163:1371-3.

Groh M, Pagnoux C, Baldini CV, Bel E, Bottero P, Cottin V, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA). Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 2015;26:545-53.

Mavrogeni SI, Dimitroulas T, Kitas GD. Cardiovascular magnetic resonance in the diagnosis and management of cardiac and vascular involvement in the systemic vasculitides. Curr Opin Rheumatol 2019;31:16-24.

Fijolek J, Wiatr E, Gawryluk D, Nowicka U, Martusewicz-Boros MM, Kober J, et al. The significance of cardiac magnetic resonance imaging in detection and monitoring of the treatment efficacy of heart involvement in eosinophilic granulomatosis with polyangiitis patients. Sarcoidosis Vasc Diffuse Lung Dis 2016;33:51-8.

Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis. Characteristics, treatment, and outcomes. J Am Coll Cardiol 2017;70:2363-75.

Boldis V, Ondriska F, Spitalska E, Reiterova K. Immunodiagnostic approaches for the detection of human toxocarosis. Exp Parasitol 2015;59:252-8.

Warrel CE, Checkley AM. The investigation of eosinophilia. Medicine 2017;46:30-7

Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005;32:1076-80.

Nguyen Y, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Semin Respir Crit Care Med 2018;39:471-81.

By Ed Uthman, MD, Houston, Texas, USA - Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=10813548

Downloads

Published

05-11-2021

Issue

Section

Original Research Articles

How to Cite

“The Role of Peripheral Eosinophilia in Diagnosing Lung Disorders: Experience from a Single Pneumonological Center”. 2021. Multidisciplinary Respiratory Medicine 16 (November). https://doi.org/10.4081/mrm.2021.770.